ViaLogy Acquiring MDx Firm Premaitha Health for $17.8M; Plans to Launch NIPT in 2015 | GenomeWeb

NEW YORK (GenomeWeb) – Investment firm ViaLogy today announced it is acquiring UK molecular diagnostics firm Premaitha Health for £10.5 million ($17.8 million) in a reverse takeover.

ViaLogy will take on the Premaitha Health name with its shares to begin trading on the London Stock Exchange's AIM market next month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.